Regulatory guidelines can vary significantly across regions. For example, the European Union has stringent regulations under its REACH framework, which requires comprehensive data on the safety of nanomaterials before they can be marketed. In contrast, the United States adopts a more flexible, case-by-case approach, particularly for medical applications.
